Page last updated: 2024-09-03

garenoxacin and Bacterial Disease

garenoxacin has been researched along with Bacterial Disease in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (76.92)	29.6817
2010's	3 (23.08)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kurokawa, M; Nakamura, F; Nannya, Y; Shinohara, A; Taoka, K; Uni, M; Yamazaki, S; Yoshimi, A	1
Endo, S; Hirai, N; Kazebayashi, Y; Kishino, S; Minami, Y; Ohsaki, Y; Onishi, K; Sasaki, T; Toyoshima, E; Yamamoto, Y	1
Kobayashi, H; Takagi, H; Tanaka, K; Tsuda, H	1
Baba, S; Fujisawa, T; Harabuchi, Y; Ikeda, F; Kobayashi, T; Kurono, Y; Nishimura, T; Suzuki, K; Ubukata, K; Yamanaka, N	1
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL	1
Hecht, DW; Osmolski, JR	1
Esposito, S; Ianniello, F; Leone, S; Noviello, S	1
Behra-Miellet, J; Dubreuil, L; Liebetrau, A; Rodloff, AC	1
Andes, D; Craig, WA	1
Bell, JM; Christiansen, KJ; Jones, RN; Turnidge, JD	1
Almassi, GH; Brown, KR; Edmiston, CE; Kehl, KS; Krepel, CJ; Lewis, BD; Loehrl, TA; Seabrook, GR; Smith, TL; Somberg, LB; Towne, JB	1
Kostrica, R; Lopez Sisniega, J; Profant, M; Waskin, H	1
Gordon, KA; Jones, RN; Pfaller, MA	1

Reviews

1 review(s) available for garenoxacin and Bacterial Disease

Article	Year
Clinical studies of garenoxacin. International journal of antimicrobial agents, 2008, Volume: 32, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clinical Trials, Phase III as Topic; Fluoroquinolones; Humans; Pneumonia, Bacterial	2008

Trials

1 trial(s) available for garenoxacin and Bacterial Disease

Article	Year
Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration. Clinical therapeutics, 2007, Volume: 29, Issue:8 Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Argentina; Bacterial Infections; Biopsy, Needle; Drug Administration Schedule; Europe; Female; Fluoroquinolones; Humans; Male; Maxillary Sinus; Maxillary Sinusitis; Middle Aged; North America; Treatment Outcome	2007

Article

Year

Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.

Clinical therapeutics, 2007, Volume: 29, Issue:8

Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Argentina; Bacterial Infections; Biopsy, Needle; Drug Administration Schedule; Europe; Female; Fluoroquinolones; Humans; Male; Maxillary Sinus; Maxillary Sinusitis; Middle Aged; North America; Treatment Outcome

2007

Other Studies

11 other study(ies) available for garenoxacin and Bacterial Disease

Article	Year
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia. Japanese journal of clinical oncology, 2015, Volume: 45, Issue:8 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size	2015
Analysis of garenoxacin distribution in the mediastinum using endobronchial ultrasound-guided transbronchial needle aspiration. International journal of antimicrobial agents, 2015, Volume: 46, Issue:6 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Biopsy, Fine-Needle; Bronchi; Bronchoscopy; Female; Fluoroquinolones; Humans; Lymph Nodes; Male; Mediastinum; Middle Aged; Ultrasonography	2015
[Antimicrobial susceptibility surveillance of recent isolates from otorhinolaryngological infections to garenoxacin and other antimicrobial drugs]. The Japanese journal of antibiotics, 2009, Volume: 62, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Humans; Otorhinolaryngologic Diseases; Time Factors	2009
Activity of garenoxacin against 536 unusual anaerobes including 128 recovered from acute pelvic infections. Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pelvic Infection	2011
Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Chicago; Culture Media; Fluoroquinolones; Indoles; Microbial Sensitivity Tests; Quinolones	2003
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:5 Topics: Anti-Infective Agents; Bacterial Infections; Colony Count, Microbial; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pyogenes; Time Factors	2003
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11 Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; Fluoroquinolones; Humans; Microbial Sensitivity Tests	2003
Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12 Topics: Animals; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluoroquinolones; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae	2003
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6 Topics: Anti-Infective Agents; Asia; Bacteria; Bacterial Infections; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pacific Ocean; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; South Africa	2004
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines	2005
BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000). The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:5 Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Indoles; Microbial Sensitivity Tests; Population Surveillance; Quinolones	2002